
JCR Pharmaceuticals
JCR has been proactively engaged in research and development (R&D) of biopharmaceuticals based on recombinant DNA technologies.
- Healthcare
- Technology
- biotechnology
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
N/A | N/A | IPO | |
Total Funding | 000k |

JPY | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | 21 % | 70 % | (33 %) | 25 % | (23 %) | 17 % | 2 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | 35 % | 44 % | 22 % | 25 % | (11 %) | 15 % | 16 % |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | 23 % | 28 % | 11 % | 13 % | (14 %) | 7 % | 6 % |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Equity research estimates
Related Content
JCR Pharmaceuticals is a biopharmaceutical company specializing in the development and commercialization of innovative treatments for rare and intractable diseases. Operating primarily in the healthcare and biotechnology sectors, JCR Pharmaceuticals serves patients, healthcare providers, and research institutions. The company's business model focuses on leveraging advanced cell and gene therapy technologies to create effective and targeted treatments. Revenue is generated through the sale of proprietary drugs, licensing agreements, and collaborative research partnerships. JCR Pharmaceuticals aims to address unmet medical needs by providing cutting-edge solutions that improve patient outcomes and quality of life.
Keywords: biopharmaceutical, rare diseases, intractable diseases, cell therapy, gene therapy, healthcare, biotechnology, innovative treatments, patient outcomes, research partnerships.
Tech stack
Investments by JCR Pharmaceuticals
Edit